https://www.nytimes.com/2022/06/29/business/mckinsey-opioid-…
Much has been disclosed over the years about McKinsey’s relationship with Purdue Pharma, including the consulting firm’s recommendation that the drug maker “turbocharge” its sales of OxyContin. But The Times found that the firm played a far deeper and broader role in advising clients involved in the opioid crisis than was publicly disclosed.
The newly released McKinsey records include more than 15 years of emails, slide presentations, spreadsheets, proposals and other documents. They provide a sweeping and detailed depiction of a firm that became a trusted adviser to companies at the core of an epidemic that has claimed half a million American lives.
https://www.nakedcapitalism.com/2022/06/new-york-times-shows…
The New York Times has just published an important new article that shows that McKinsey’s conduct in the opioids crisis was even more deadly than widely realized, by virtue of the giant consulting firm advising opioids merchants beyond just the notorious Purdue Pharma. And as with Purdue, McKinsey strategies to navigate around regulations and boost sales generated more fatalities.
Like Jamie Dimon*, McKinsey paid a ~$600 million fine admitted no wrong doing and moved along. As long the wrong generate sufficient funds to pay any fine, anything goes in US business world.
*https://www.dividend.com/dividend-education/a-brief-history-…